Whether youre looking for weight loss or vitamin injections to help you support your progress and reach your goals, our expert team can help you get the most out of every visit
The appropriate pathway depends on clinician judgment, patient-specific medical factors, insurance coverage, regulatory status, and out-of-pocket cost
Lean tirzepatide when: Maximum weight loss is the goal (target greater than 20%) You have T2D with significant insulin resistance (SURPASS-2: 11.2 kg tirzepatide vs 5.7 kg semaglutide) You have moderate-to-severe obstructive sleep apnea with obesity (Zepbound is the only FDA-approved pharmacotherapy) You plateaued on semaglutide after 12+ months You have MASH and need the drug with the strongest resolution data (SYNERGY-NASH: 44 to 62% resolution) Your insurance covers Zepbound or Mounjaro You tolerated the 2.5 mg starting dose well during a prior trial Lean semaglutide when: You have established cardiovascular disease or high CV risk
In clinical trials, anxiety was reported in: 5% to 6% of adults who took Vyvanse, depending on the condition being treated 0% to 1% of adults who took a placebo (a treatment containing no active drug) Its not known how often anxiety may have occurred in children who took Vyvanse in clinical studies
Every decision was guided by usability, flexibility, and a consistent visual language
